Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Molecular Models02:00

Molecular Models

43.8K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.8K
Molecular Orbital Theory II03:51

Molecular Orbital Theory II

27.7K
Molecular Orbital Energy Diagrams
27.7K
Molecular Orbital Theory I02:35

Molecular Orbital Theory I

47.8K
Overview of Molecular Orbital Theory
47.8K
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

46.1K
VSEPR Theory for Determination of Electron Pair Geometries
46.1K
Molecular and Ionic Solids02:54

Molecular and Ionic Solids

20.2K
Crystalline solids are divided into four types: molecular, ionic, metallic, and covalent network based on the type of constituent units and their interparticle interactions.
Molecular Solids
Molecular crystalline solids, such as ice, sucrose (table sugar), and iodine, are solids that are composed of neutral molecules as their constituent units. These molecules are held together by weak intermolecular forces such as London dispersion forces, dipole-dipole interactions, or hydrogen bonds, which...
20.2K
Kinetic Molecular Theory: Molecular Velocities, Temperature, and Kinetic Energy03:07

Kinetic Molecular Theory: Molecular Velocities, Temperature, and Kinetic Energy

29.9K
The kinetic molecular theory qualitatively explains the behaviors described by the various gas laws. The postulates of this theory may be applied in a more quantitative fashion to derive these individual laws.
29.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retroperitoneal Schwannoma with a Novel <i>PRCC::TFE3</i> Fusion: Expanding the Spectrum of Schwannomas with a <i>TFE3</i> Gene Rearrangement.

International journal of surgical pathology·2026
Same author

Preserving Medical Education in Conflict Zones through Transnational Partnerships: Field Lessons from Gaza and Ukraine.

Disaster medicine and public health preparedness·2026
Same author

Ayushman Arogya Mandir and India's progress toward Universal Health Coverage: A narrative review.

Journal of family medicine and primary care·2026
Same author

Survival comparison analysis between cervical squamous cell carcinoma and adenocarcinoma with a special focus on the HPV status.

Gynecologic oncology·2026
Same author

Comparison of breast and gastric HER2 immunohistochemistry (IHC) scoring criteria in the assessment of endometrial carcinoma.

Gynecologic oncology·2025
Same author

Impact of molecular and immune signature on endometrial biopsies with atypical hyperplasia with and without concurrent endometroid carcinoma.

Gynecologic oncology reports·2025

Related Experiment Video

Updated: Feb 10, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.7K

Gynecologic Cancers: Molecular Updates 2018.

Eman Abdulfatah1, Quratulain Ahmed2, Baraa Alosh1

  • 1Department of Pathology, Detroit Medical Center Harper University Hospital, Wayne State University, 3990 John R Detroit, MI 48201, USA.

Clinics in Laboratory Medicine
|May 20, 2018
PubMed
Summary

Ovarian carcinoma poses significant health risks. Integrating molecular markers with clinical data can improve cancer diagnosis, prognosis, and personalized treatment strategies for patients.

Keywords:
Cell free nucleic acidEndometrial carcinomaMolecular pathogenesisOvarian carcinomaUterine carcinoma

More Related Videos

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
07:01

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

10.8K
OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery
05:31

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

Published on: May 9, 2021

4.7K

Related Experiment Videos

Last Updated: Feb 10, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.7K
Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
07:01

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

10.8K
OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery
05:31

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

Published on: May 9, 2021

4.7K

Area of Science:

  • Gynecologic Oncology
  • Molecular Pathology
  • Cancer Biomarkers

Background:

  • Ovarian carcinoma remains a significant cause of morbidity and mortality in women.
  • Current diagnostic and prognostic tools require enhancement for improved patient outcomes.
  • The need for personalized medicine in gynecologic malignancies is increasingly recognized.

Purpose of the Study:

  • To explore the potential of emerging molecular markers in ovarian carcinoma.
  • To investigate the utility of an integrated clinicopathologic and molecular classification system.
  • To enhance the accuracy of clinical risk prediction and treatment tailoring for gynecologic cancers.

Main Methods:

  • Review of emerging molecular markers relevant to ovarian carcinoma.
  • Analysis of clinicopathologic data in conjunction with molecular profiles.
  • Development of a framework for integrated classification of gynecologic malignancies.

Main Results:

  • Emerging molecular markers show promise for improved diagnosis and prognosis.
  • An integrated approach offers a more refined risk stratification for patients.
  • Personalized treatment recommendations can be better informed by combined data.

Conclusions:

  • Integrated clinicopathologic and molecular classification is crucial for advancing ovarian carcinoma care.
  • This approach has the potential to significantly improve patient risk prediction.
  • Tailored therapeutic strategies based on integrated data can optimize treatment outcomes.